作者
梁 华,江国英
文章摘要
目的:探讨雷公藤内酯醇(TP)通过调控miR-7及PTEN/PI3K/Akt通路促进系统性红斑狼疮(SLE)B细胞凋亡的分子机制,为SLE治疗提供理论依据。方法:基于Web of Science及中国知网数据库检索2004-2025年相关文献,结合分子生物学实验假设,分析TP对miR-7、PTEN/PI3K/Akt通路及B细胞凋亡的调控关系,并总结现有研究进展与争议点。结论:TP可能通过上调miR-7抑制PTEN表达,间接激活PI3K/Akt通路,诱导SLE B细胞凋亡;miR-7在SLE中呈现异常高表达,其与PTEN的靶向关系形成"负负得正"的调控网络。讨论:TP调控miR-7的具体机制及通路异质性需进一步验证,未来需结合单细胞测序与临床队列研究明确其亚型特异性及转化潜力。
文章关键词
雷公藤内酯醇;miR-7;PTEN/PI3K/Akt通路;系统性红斑狼疮
参考文献
[1] Li Z,Bai Y,Wu H,et al.PTEN/PI3K/AKT pathway activation with hypoxia-induced human umbilical vein endothelial cell exosome for angiogenesis-based diabetic skin reconstruction.[J].Materials today.Bio,2025,32101651.
[2] Wangriatisak K,Vries D C,Sharma K R,et al.Association between peripheral activated naive and double negative 2 B-cell subsets and clinical parameters in lupus nephritis patients.[J].Scandinavian journal of immunology,2024,101(1):e13427.
[3] 汤艳华,刘玲,刘炬,等.雷公藤内酯醇调控JAK/STAT信号通路对系统性红斑狼疮模型小鼠炎症免疫的影响[J].中药材,2021, 44(08):1976-1980.
[4] 刘玉芳,秦桂芳.雷公藤内酯醇对诱发性红斑狼疮小鼠模型的实验研究[J].中国中医急症,2018,27(08):1379-1382+1386.
[5] Chen Y,Mei Y,Zou C,et al.Aberrant Lower CD6 Expression on Peripheral B Cells Associated With Liver/Kidney Injury and Autoantibody Production of Systemic Lupus Erythematosus Patients.[J].Scandinavian journal of immunology,2025,101(4):e70018.
[6] Zhang C,Lu Y.MiR-223 within neutrophil axis promotes Th17 expansion by PI3K-AKT pathway in systemic lupus erythematosus[J]. Arthritis Research&Therapy,2025,27(1):21-21.
[7] Li X,Zhu Q,Yang Z,et al.The Jieduquyuziyin Prescription alleviates systemic lupus erythematosus by modulating B cell metabolic reprogramming via the AMPK/PKM2 signaling pathway.[J].Journal of ethnopharmacology,2025,345 119626.
[8] 田莉,陈容,李娜.miR-146a调控PI3K/AKT通路对宫颈癌细胞增殖、迁移、侵袭的影响及对FOXP3表达的调节作用[J].中国老年学杂志,2025,45(04):893-900.
[9] 冯静,谷连元,饶莉,等.雷公藤多苷联合贝利尤单抗对系统性红斑狼疮患者外周血淋巴细胞VCS参数及JAK2/STAT3信号通路的影响[J/OL].中药材,2024,(10):2628-2633[2025-04-25].
[10] 达古拉,王静,王勇,等.miR-7抑制剂治疗MRL/lpr小鼠的实验性研究[J].中国免疫学杂志,2024,40(04):680-685+692.
[11] Lin Y S,Yu Y,Nie D,et al.Single-cell RNA sequencing reveals the heterogeneity and regulatory modules of cell-specific RNA-binding proteins in patients with systemic lupus erythematosus.[J].Biochemistry and biophysics reports,2025,42 101977.
[12] Rose J.Autoimmune Connective Tissue Diseases:Systemic Lupus Erythematosus and Rheumatoid Arthritis.[J].Rheumatic diseases clinics of North America,2025,51(2):347-359.
Full Text:
DOI